CBD improved blood sugar, energy use, and bone density in menopausal mice while boosting gut bacteria

Ovariectomized mice treated with CBD for 18 weeks showed improved glucose tolerance, increased energy expenditure, better bone density, and a bloom in beneficial Lactobacillus gut bacteria.

Sui, Ke et al.·Frontiers in pharmacology·2022·Preliminary EvidenceAnimal StudyAnimal Study
RTHC-04249Animal StudyPreliminary Evidence2022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

CBD-treated ovariectomized mice had improved oral glucose tolerance, increased energy expenditure, and improved bone mineral density and bone microarchitecture. These improvements were accompanied by increased Lactobacillus abundance in the gut and gene expression changes consistent with reduced inflammation.

Key Numbers

CBD dose: 25 mg/kg for 18 weeks. Improved whole body bone mineral density and content. Increased femoral bone volume fraction, trabecular thickness, and volumetric bone density. Increased Lactobacillus abundance. Gene expression changes indicated reduced inflammation and less bone resorption.

How They Did This

Ovariectomized (OVX) and sham surgery mice received CBD (25 mg/kg) or vehicle perorally for 18 weeks. Assessed glucose tolerance, energy expenditure, bone density (DXA and micro-CT), gut microbiome composition, and gene expression in intestine and femur.

Why This Research Matters

Postmenopausal women face increased risks of metabolic disease and osteoporosis with limited treatment options. If CBD can address multiple aspects of this risk profile while modifying the gut microbiome, it could offer a novel therapeutic approach.

The Bigger Picture

The connection between CBD, gut microbiome, and bone health is a novel finding that bridges several active areas of research and could open new avenues for managing postmenopausal health.

What This Study Doesn't Tell Us

Animal study in mice, so results may not translate to humans. Single CBD dose tested. The ovariectomy model approximates but does not fully replicate human menopause. Gut microbiome differences between mice and humans limit direct translation.

Questions This Raises

  • ?Would these effects be seen in postmenopausal women?
  • ?Is the gut microbiome change (Lactobacillus bloom) a mediator of the metabolic and bone benefits?
  • ?What is the optimal CBD dose and duration for bone health?

Trust & Context

Key Stat:
Improved bone density, glucose tolerance, and energy expenditure simultaneously
Evidence Grade:
Preliminary: single animal study with one dose, no human data.
Study Age:
Published in 2022.
Original Title:
Cannabidiol-Treated Ovariectomized Mice Show Improved Glucose, Energy, and Bone Metabolism With a Bloom in Lactobacillus.
Published In:
Frontiers in pharmacology, 13, 900667 (2022)
Database ID:
RTHC-04249

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

How did CBD affect bones?

CBD improved whole body bone mineral density and content, increased femoral bone volume and trabecular thickness, and shifted gene expression toward less bone breakdown (resorption).

What role did gut bacteria play?

CBD-treated mice had a significant increase in Lactobacillus species in the gut. These beneficial bacteria have been linked to improved metabolism and reduced inflammation, potentially mediating some of CBD's effects.

Could postmenopausal women benefit from CBD?

These preclinical results are promising, but human clinical trials are needed. The researchers explicitly call for further investigation of CBD as a therapeutic for postmenopause-related disorders.

Read More on RethinkTHC

Cite This Study

RTHC-04249·https://rethinkthc.com/research/RTHC-04249

APA

Sui, Ke; Tveter, Kevin M; Bawagan, Fiona G; Buckendahl, Patricia; Martinez, Savannah A; Jaffri, Zehra H; MacDonell, Avery T; Wu, Yue; Duran, Rocio M; Shapses, Sue A; Roopchand, Diana E. (2022). Cannabidiol-Treated Ovariectomized Mice Show Improved Glucose, Energy, and Bone Metabolism With a Bloom in Lactobacillus.. Frontiers in pharmacology, 13, 900667. https://doi.org/10.3389/fphar.2022.900667

MLA

Sui, Ke, et al. "Cannabidiol-Treated Ovariectomized Mice Show Improved Glucose, Energy, and Bone Metabolism With a Bloom in Lactobacillus.." Frontiers in pharmacology, 2022. https://doi.org/10.3389/fphar.2022.900667

RethinkTHC

RethinkTHC Research Database. "Cannabidiol-Treated Ovariectomized Mice Show Improved Glucos..." RTHC-04249. Retrieved from https://rethinkthc.com/research/sui-2022-cannabidioltreated-ovariectomized-mice-show

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.